Gossamer Bio, Inc.
Gossamer Bio, Inc. (GOSS) Revenue
Annual & quarterly revenue history · segment & region breakdown
GOSS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsGossamer Bio, Inc. trailing twelve-month (TTM) revenue is $0.06B, a decrease of 57.74% year-over-year from $0.05B in FY2025.
Revenue trend
2025 – 2016 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.05B | -$0.07B | -57.74% |
| 2024-12-31 | $0.11B | +$0.11B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | +$0.00B | — |
| 2018-12-31 | $0.00B | +$0.00B | — |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | — | — |
Compare revenue vs peers
BiotechnologyCompare GOSS revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Gossamer Bio, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Gossamer Bio, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Gossamer Bio, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GOSS revenue · 4 questionsGOSS's trailing twelve-month (TTM) revenue is $0.06B. That is a decrease of 57.74% year-over-year from $0.05B in FY2025.
▸ Source: FMP · Gossamer Bio, Inc. SEC filings · GAAP · Gossamer Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026